TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/18/23 18:29 | 12/14/23 | RAIN | Rain Oncology Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tang Kevin C | CA | T | S.m | -209 | 1.20 | 0 | -174 | -4 | 3,851 | I | |||||||||||||||
12/1/21 19:07 | 11/29/21 | LJPC | La Jolla Pharmaceutical Co | CA | Health | BioPrd | Biological Products, (No Diag | Tang Kevin C | CA | DT | S.m | -1,734 | 3.93 | 0 | -441 | -4 | 9,608 | I | |||||||||||||||
11/26/21 13:02 | 11/23/21 | APVO | Aptevo Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tang Kevin C | CA | H | Exit Fil | S | -10,368 | 11.25 | 0 | -921 | -100 | 0 | I | ||||||||||||||
11/22/21 17:26 | 11/18/21 | APVO | Aptevo Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tang Kevin C | CA | T | S.m | -6,500 | 7.75 | 0 | -839 | -48 | 921 | I | |||||||||||||||
11/19/21 16:38 | 11/17/21 | ODT | Odonate Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tang Kevin C | CA | DOT | CEO | S.m | -5,731 | 2.09 | 0 | -2,747 | -18 | 12,767 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |